new glp 1 drug retatrutide Back in 2023 we saw truly unprecedented data for a called ' Retatrutide', which binds to — and activates — 3 receptors: the GLP1 receptor (like Semaglutide), the GIP receptor (like Retatrutide for weight loss: Study

Nevertheless, preliminary findings suggest that it can maintain weight loss for up to 5 years, given adherence to dietary and lifestyle changes

So we go down on the dosing essentially a trial of what some would call micro-dosing-- and check in periodically to make sure you arent drifting away from the weight loss goals you achieved. Dr

International Journal of Obesity , 2023, 47.10: 883-892

But these uses arent FDA-approved

Because GLP-1 medications can sometimes affect appetite and nutrient intake, they may influence how quickly the body bounces back

Supplied as a lyophilized powder, manufactured under controlled conditions, and quality tested prior to release